Majority of CFOs at struggling hospitals expect to lose their jobs by 2016

Sixty-one percent of chief financial officers at self-identified struggling hospitals anticipate losing their jobs within two years, reports Becker’s Healthcare.

This finding came from a Black Book survey that analyzed responses from 590 hospital and inpatient organizations across 45 states.

Read more below:

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.